Latest Breaking News On - Chromium single cell - Page 1 : vimarsana.com

10x Genomics, Inc Share Price Target $58 50 , now 21 7% Upside Potential

10x Genomics, Inc. Share Price Target '$58.50', now 21.7% Upside Potential

Genomics incChromiumx seriesChromium connectChromium controllerChromium single cell gene expressionChromium single cell gene expression flexChromium single cell immune profilingChromium single cellChromium single cell multiomeGene expressionVisium spatial gene expressionVisium spatial proteogenomicsXenium in situ gene

Integrative Study Conducted by 10x Genomics Combines Single Cell, Spatial and In Situ Analyses to Investigate Tumor Invasiveness

Integrative Study Conducted by 10x Genomics Combines Single Cell, Spatial and In Situ Analyses to Investigate Tumor Invasiveness
kptv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kptv.com Daily Mail and Mail on Sunday newspapers.

Sarah taylorAmanda janesickNature communicationsGenomics incGenomics applications teamChromium single cellVisium spatialXenium in situSingle cell gene expression flexChromium flexCytassist spatial gene expressionSenior directorSenior scientistGenomics applications

10x Genomics, Inc - Consensus buy rating and 21 0% Upside Potential

10x Genomics, Inc. - Consensus 'buy' rating and 21.0% Upside Potential

Paylocity holding corporationGenomics incChromiumx seriesChromium connectChromium controllerChromium single cell gene expressionChromium single cell gene expression flexChromium single cell immune profilingChromium single cellChromium single cell multiomeGene expressionVisium spatial gene expressionVisium spatial proteogenomicsXenium in situ gene

Beckman Coulter Life Sciences partners with 10x Genomics

Beckman Coulter Life Sciences and 10x Genomics partner to enable single cell workflow automation

Sarah nadinEileen hanniganGenomics incBeckman coulter life sciencesAssay developmentIndustry newsLiquid handlerCoulter life sciencesChromium single cellBeckman coulter lifeBeckman coulter life sciences partners with 10x genomics workflow automation

10x Genomics, Inc - Consensus buy rating and 71 0% Upside Potential

10x Genomics, Inc. - Consensus 'buy' rating and 71.0% Upside Potential

Genomics incChromiumx seriesChromium connectChromium controllerChromium single cell gene expressionChromium single cell gene expression flexChromium single cell immune profilingChromium single cellChromium single cell multiomeGene expressionVisium spatial gene expressionVisium spatial proteogenomicsXenium in situ gene